Contact this trialFirst, we need to learn more about you.
Device
Blood Pressure Monitoring for Kidney Failure
Recruiting1 award3 criteria
New York, New York
This trial is testing a new hemodialysis system and monitor in people with end-stage kidney disease. The trial is open label, which means that participants and researchers will know which treatment the participants are receiving. The trial is non-randomized, which means that participants will not be assigned to different groups by chance. The trial is post-market, which means that the new system and monitor have already been approved for use.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.